Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study

Open Forum Infectious Diseases
Barbara HasseS Yerly

Abstract

The factors that contribute to increasing obesity rates in human immunodeficiency virus (HIV)-positive persons and to body mass index (BMI) increase that typically occurs after starting antiretroviral therapy (ART) are incompletely characterized. We describe BMI trends in the entire Swiss HIV Cohort Study (SHCS) population and investigate the effects of demographics, HIV-related factors, and ART on BMI change in participants with data available before and 4 years after first starting ART. In the SHCS, overweight/obesity prevalence increased from 13% in 1990 (n = 1641) to 38% in 2012 (n = 8150). In the participants starting ART (n = 1601), mean BMI increase was 0.92 kg/m(2) per year (95% confidence interval, .83-1.0) during year 0-1 and 0.31 kg/m(2) per year (0.29-0.34) during years 1-4. In multivariable analyses, annualized BMI change during year 0-1 was associated with older age (0.15 [0.06-0.24] kg/m(2)) and CD4 nadir <199 cells/µL compared to nadir >350 (P < .001). Annualized BMI change during years 1-4 was associated with CD4 nadir <100 cells/µL compared to nadir >350 (P = .001) and black compared to white ethnicity (0.28 [0.16-0.37] kg/m(2)). Individual ART combinations differed little in their contribution to BMI change. ...Continue Reading

References

Mar 1, 1990·Archives of Internal Medicine·D F WilliamsonR F Anda
Nov 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J P PalenicekA J Saah
Nov 2, 1995·The New England Journal of Medicine·K M FlegalS M Campbell
Nov 6, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J J MaasI P Keet
Mar 17, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·D P KotlerR N Pierson
Mar 9, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·G Shor-PosnerM K Baum
Sep 28, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Enos BernasconiUNKNOWN Swiss HIV Cohort Study
Jun 12, 2003·JAMA : the Journal of the American Medical Association·Sharon A RiddlerLawrence A Kingsley
Dec 6, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Phyllis C TienCarl Grunfeld
Sep 28, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Peter BacchettiUNKNOWN Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)
Sep 19, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Todd BrownAdrian S Dobs
Jan 26, 2008·HIV Medicine·A NguyenUNKNOWN Swiss HIV Cohort Study
Dec 17, 2008·AIDS Patient Care and STDs·Nancy Crum-CianfloneAnuradha Ganesan
May 7, 2009·AIDS·Richard H HaubrichUNKNOWN AIDS Clinical Trials Group (ACTG) A5142 Study Team
Dec 2, 2009·International Journal of Epidemiology·UNKNOWN Swiss HIV Cohort StudyPatrick Francioli
Apr 27, 2010·PloS One·Nancy Crum-CianfloneUNKNOWN Infectious Disease Clinical Research Program HIV Working Group
May 27, 2010·AIDS·Carl GrunfeldUNKNOWN Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)
Dec 16, 2010·JAMA : the Journal of the American Medical Association·Arlene L HankinsonStephen Sidney
Jun 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Grace A McComseyEric S Daar
Jan 19, 2012·JAMA : the Journal of the American Medical Association·Katherine M FlegalCynthia L Ogden
Sep 7, 2012·Antiviral Therapy·Tyler TateMichael J Mugavero
Jan 3, 2013·JAMA : the Journal of the American Medical Association·Katherine M FlegalBarry I Graubard
Mar 6, 2013·JAMA Internal Medicine·Matthew S FreibergAmy C Justice

❮ Previous
Next ❯

Citations

Jul 2, 2016·Current Opinion in HIV and AIDS·Keri N AlthoffAmy C Justice
Sep 15, 2016·The Journal of Infectious Diseases·John R KoetheSuzanne Filteau
Mar 14, 2017·Virulence·Esteban Martinez
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jordan E LakeKristine M Erlandson
Mar 14, 2018·Journal of the International Association of Providers of AIDS Care·Alexander KintuWafaie Fawzi
Jun 18, 2018·Gerontology·Tanja EngelPhilip E Tarr
Dec 7, 2018·Frontiers in Endocrinology·João Sérgio NevesPaula Freitas
Apr 27, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·John R KoetheUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
Sep 1, 2016·Expert Review of Endocrinology & Metabolism·Marianthi Papagianni, Konstantinos Tziomalos
Apr 3, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Aaron P ThriftElizabeth Y Chiao
Feb 20, 2020·Current HIV/AIDS Reports·Samuel S BailinJohn R Koethe
Oct 14, 2020·AIDS·Chloe OrkinElizabeth A Martin
Apr 11, 2021·Journal of the International AIDS Society·Patrick Wg MallonGregory P Fusco
Aug 8, 2021·International Journal of Epidemiology·Alexandra U ScherrerUNKNOWN Swiss HIV Cohort Study (SHCS)

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.